Radiometer launches new point-of-care test for procalcitonin, aiding diagnosis of sepsis

Radiometer has launched a rapid, acute care procalcitonin (PCT) assay to aid in the diagnosis of sepsis, further extending the AQT90 FLEX test menu

June 25, 2015

Sepsis is the most prevalent and severe infection-related condition and can be difficult to identify, particularly in the initial stages. This presents a considerable diagnostic challenge to emergency department and intensive care clinicians. Undetected, it can quickly progress to severe sepsis or septic shock and, as its severity increases, mortality rates can reach 50 %. In septic patients with hypotension, a delay of just one hour in administering antibiotic therapy increases the risk of mortality by 7 %, making early identification of sepsis and initiation of appropriate antibiotic treatment vital. Radiometer’s AQT90 FLEX PCT assay enables early and convenient measurement of PCT – the biomarker of choice to aid diagnosis of sepsis – with results available to treating physicians in less than 21 minutes.

The easy-to-use AQT90 FLEX PCT assay is a key aid for timely diagnosis and treatment of sepsis. Procalcitonin, normally present in the blood at a very low level, is released in larger amounts in response to an infection, acting as a risk indicator for sepsis. With a negative predictive value above 95 %, it is widely acknowledged as the most sensitive biomarker to aid diagnosis of bacterial sepsis. The AQT90 FLEX PCT assay offers laboratory quality, quantitative determination of procalcitonin in whole blood or plasma at the point of patient care. Prehandling of whole blood samples is not required and turnaround times are improved, enabling earlier detection of sepsis for better patient outcomes.

To learn more, go to radiometer.com/PCT

Cookies are used on this website

Use of cookies

Don't show this message again

YES REQUEST ACCESS

Radiometer is using MICROSOFT AZURE AD to authenticate customer access. If you are already registered please click YES and you will be taken directly to the authentication portal to sign in using your MICROSOFT AD credentials. If you are unsure, please select REQUEST ACCESS and we will guide you through the sign-in process.

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

Allow the use of existing Active Directory credentials
Single-sign on experience
Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)

ABOUT THIS POLICY

Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.

“Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.

SCOPE

This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.

There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.